Table of Contents
Overview
New York, NY – April 03, 2025 – The Global Peripheral Stent Implants Market size is expected to be worth around USD 7.1 Billion by 2033 from USD 3.9 Billion in 2023, growing at a CAGR of 6.1% during the forecast period from 2024 to 2033.
The global market for peripheral stent implants is witnessing significant growth, driven by the rising prevalence of peripheral artery disease (PAD) and advancements in minimally invasive treatments. Peripheral stents are small, expandable mesh tubes designed to restore blood flow in narrowed or blocked arteries outside the heart, primarily in the legs.
The increasing incidence of PAD, fueled by aging populations, diabetes, and smoking, has heightened the demand for innovative stent technologies. Drug-eluting and bioresorbable stents are emerging as key advancements, offering improved long-term outcomes and reduced restenosis rates. Additionally, ongoing clinical research and regulatory approvals are further strengthening market expansion.
Leading medical device manufacturers are investing in next-generation stent designs, enhancing flexibility, durability, and biocompatibility. The growing adoption of minimally invasive procedures, coupled with favorable reimbursement policies, is expected to drive further market growth. With technological advancements and rising awareness, the peripheral stent implants market is poised for sustained expansion, offering improved treatment options for millions of patients worldwide.
Key Takeaways
- Market Size: The Peripheral Stent Implants Market is projected to reach USD 7.1 billion by 2033, growing from USD 3.9 billion in 2023.
- Market Growth: The market is expected to expand at a CAGR of 6.1% during the forecast period (2024–2033).
- Product Analysis: Bare Metal Stents (BMS) dominated the market in 2023, accounting for an exceptional 76.0% share.
- Artery Type Analysis: Among artery types, Iliac Stents held a 47.6% market share in 2023.
- End-Use Analysis: Hospitals emerged as the leading end-use segment, capturing 58.1% of the market share in 2023.
- Regional Analysis: The United States led the market with an estimated 42.8% share, generating USD 1.6 billion in revenue.
- Technological Advancements: Leading companies such as Medtronic and Abbott Laboratories continue to drive innovation in peripheral stent implants by enhancing design, materials, and drug-eluting technologies to improve patient outcomes.
- Global Market Expansion: Major healthcare players like iVascular SLU and Cardinal Health are expanding their global presence through strategic partnerships and distributor collaborations, aiming to reach broader patient populations.
Segmentation Analysis
Product Analysis: The Peripheral Stent Implants Market comprises Bare Metal Stents (BMS), Covered Stents, and Drug-Eluting Stents (DES). BMS hold a dominant 76.0% market share due to their durability and ability to maintain vessel patency. Covered Stents provide precise deployment and vascular sealing, ideal for complex cases. DES release medication gradually, preventing restenosis and improving long-term outcomes. These three technologies collectively enhance treatment options for peripheral arterial diseases (PAD) by ensuring optimal blood flow.
Artery Type Analysis: By artery type, Iliac Stents lead the market with a 47.6% share, effectively treating iliac artery diseases affecting the pelvis and legs. Femoral-Popliteal Stents address blockages in the thigh and lower leg arteries, ensuring better circulation. Renal Stents manage renal artery stenosis, improving kidney function. Carotid Stents prevent strokes by treating carotid artery disease. This diverse segmentation highlights the market’s commitment to providing tailored vascular solutions for various arterial conditions.
End-User Analysis: Hospitals dominate the market with a 58.1% share, being the primary providers of complex stent implantations due to their advanced facilities. Ambulatory Surgical Centers (ASCs) also hold a significant share, offering efficient, minimally invasive procedures for less complicated cases. ASCs help reduce hospital burdens while enhancing patient accessibility and flexibility in treatment. The presence of both hospitals and ASCs reflects the market’s focus on innovative, patient-centric solutions for peripheral arterial diseases.
Market Segments
Product
- Bare Metal Stents (BMS)
- Covered Stents
- Drug-Eluting Stents (DES)
Artery Type
- Iliac Stents
- Femoral-popliteal Stents
- Renal and Related Stents
- Carotid Stents
End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Analysis
In 2023, the United States accounted for approximately 42.8% of the global PAD market, generating USD 1.6 billion in revenue. This growth is primarily driven by the rising prevalence of PAD, influenced by factors such as higher smoking rates, sedentary lifestyles, poor dietary habits, diabetes, and an aging population—all of which contribute to increased cardiovascular and cerebrovascular diseases.
According to the Centers for Disease Control and Prevention (CDC), as of 2022, an estimated 6.5 million adults aged 40 and above in the U.S. had been diagnosed with peripheral artery disease (PAD). It is important to note that PAD symptoms often overlap with other arterial disorders, and while atherosclerosis is a major contributor, it does not fully account for all PAD cases.
Emerging Trends
- Development of Drug-Eluting Stents (DES): Building upon the success of paclitaxel in preventing restenosis, newer-generation DES are designed to release medication slowly over extended periods, such as 12 months, to maintain artery openness and reduce the need for repeat procedures.
- Advent of Bioresorbable Stents: Innovations like Abbott’s Esprit BTK System introduce dissolvable stents that not only keep arteries open but also deliver drugs to aid in vessel healing, representing a significant advancement in treating conditions like chronic limb-threatening ischemia.
- Enhanced Imaging Techniques: The integration of advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), into stenting procedures enables precise placement and assessment of stents, improving procedural success rates and patient safety.
- Minimally Invasive Procedures: There is a growing preference for minimally invasive endovascular treatments over traditional open surgeries. These procedures, including angioplasty with stent placement, offer benefits such as reduced recovery times and lower complication rates, making them increasingly popular among patients and healthcare providers.
Use Cases
- Treatment of Peripheral Artery Disease (PAD): PAD affects over 200 million individuals worldwide, leading to narrowed arteries in the limbs. Stent implantation helps keep these arteries open, alleviating symptoms like leg pain and reducing the risk of severe complications.
- Management of Iliac Artery Occlusions: Stents are commonly used in the iliac arteries, with studies reporting immediate technical success rates of approximately 96% when combining angioplasty and stenting for aorto-iliac occlusive disease.
- Addressing Femoral-Popliteal Artery Lesions: Stenting in the femoral and popliteal arteries is employed to treat blockages in the thigh and knee regions, improving blood flow and mobility in affected patients.
- Repair of Arterial Aneurysms and Trauma: Covered stents are utilized in cases of aneurysms, arterial trauma, or ruptures to seal the affected area and prevent further complications, offering a less invasive alternative to open surgical repair.
- Prevention of Stroke in Carotid Artery Disease: Carotid stenting is performed to open narrowed carotid arteries in the neck, reducing the risk of stroke in patients with significant carotid artery disease.
Conclusion
The Peripheral Stent Implants Market is set for sustained growth, driven by the rising prevalence of peripheral artery disease (PAD) and advancements in minimally invasive stent technologies. Innovations such as drug-eluting and bioresorbable stents, along with enhanced imaging techniques, are improving patient outcomes and procedural success rates. With the United States leading the market and hospitals being the dominant end-user, the sector is witnessing robust expansion. Favorable reimbursement policies and increasing adoption of endovascular procedures further support market growth. As medical device companies continue to invest in next-generation stents, the market will play a crucial role in improving global vascular health.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
